Cargando…
Adjuvant Drug-Assisted Bone Healing: Advances and Challenges in Drug Delivery Approaches
Bone defects of critical size after compound fractures, infections, or tumor resections are a challenge in treatment. Particularly, this applies to bone defects in patients with impaired bone healing due to frequently occurring metabolic diseases (above all diabetes mellitus and osteoporosis), chron...
Autores principales: | Rothe, Rebecca, Hauser, Sandra, Neuber, Christin, Laube, Markus, Schulze, Sabine, Rammelt, Stefan, Pietzsch, Jens |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7284517/ https://www.ncbi.nlm.nih.gov/pubmed/32384753 http://dx.doi.org/10.3390/pharmaceutics12050428 |
Ejemplares similares
-
Microdialysis Reveals Anti-Inflammatory Effects of Sulfated Glycosaminoglycanes in the Early Phase of Bone Healing
por: Schulze, Sabine, et al.
Publicado: (2023) -
Impact of Sulfated Hyaluronan on Bone Metabolism in Diabetic Charcot Neuroarthropathy and Degenerative Arthritis
por: Schulze, Sabine, et al.
Publicado: (2022) -
Eph Receptors and Ephrin Ligands: Important Players in Angiogenesis and Tumor Angiogenesis
por: Mosch, Birgit, et al.
Publicado: (2010) -
Radiopharmacologist’s and Radiochemist’s
View on Targeting the Eph/Ephrin Receptor Tyrosine Kinase System
por: Neuber, Christin, et al.
Publicado: (2020) -
Advances and Challenges of Liposome Assisted Drug Delivery
por: Sercombe, Lisa, et al.
Publicado: (2015)